日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Fusobacterium nucleatum promotes metastasis of breast cancer via the miR-21-3p/FOXO3 axis

具核梭杆菌通过 miR-21-3p/FOXO3 轴促进乳腺癌转移

Huang, Yiping; Guo, Zhongzhong; Zeng, Zhaoyou; Shang, Chenyu; Zhang, Yingfeng; Ran, Ziwei; Luo, Guoqing; Shen, Sandi; Liu, Yaqin; Zhou, Peng; Ma, Peng; Zhang, Yanxia; Lin, Haibiao; Lu, Yang; Liu, Dongdong

Differentiation of inflammatory pseudotumors and malignant pulmonary nodules using the time-to-peak in first-pass dual-input volume computed tomography-perfusion

利用首过双输入容积CT灌注成像的达峰时间鉴别炎性假瘤和恶性肺结节。

Guo, Chengwei; Zhang, Xiaobo; Shen, Sandi; Chen, Weijun; Wang, Xuejing; Zhao, Liang; Han, Shuqing

[Targeting chimera technology: A new tool for undruggable in breast cancer]

【靶向嵌合体技术:乳腺癌难治性肿瘤的新治疗工具】

Chen, Zhongwu; Shen, Sandi; Song, Xiaoyu; Xiao, Bin

Bioinformatics analysis of the clinical significance of HLA class II in breast cancer

利用生物信息学分析HLA II类分子在乳腺癌中的临床意义

Wu, Guihua; Xiao, Gaofang; Yan, Yuhang; Guo, Chengwei; Hu, Ningdong; Shen, Sandi

A small molecular inhibitor of LRRK1 identified by homology modeling and virtual screening suppresses osteoclast function, but not osteoclast differentiation, in vitro.

通过同源建模和虚拟筛选鉴定出的 LRRK1 小分子抑制剂在体外可抑制破骨细胞功能,但不能抑制破骨细胞分化

Si Mingjue, Zeng Canjun, Goodluck Helen, Shen Sandi, Mohan Subburaman, Xing Weirong

Prediction model of lymphovascular invasion based on clinicopathological factors in Chinese patients with invasive breast cancer

基于临床病理因素的中国浸润性乳腺癌患者淋巴血管侵犯预测模型

Shen, Sandi; Wu, Guihua; Xiao, Gaofang; Du, Richang; Hu, Ningdong; Xia, Xu; Zhou, Haibo

Parity association with clinicopathological factors in invasive breast cancer: a retrospective analysis

生育次数与浸润性乳腺癌临床病理因素的相关性:一项回顾性分析

Shen, Sandi; Zhong, Shizhen; Xiao, Gaofang; Zhou, Haibo; Huang, Wenhua